Home » Newsletters » BioWorld Science

BioWorld Science

April 28, 2011

View Archived Issues

Novel oncolytic agent RX-5902 presented

MCT 4 expression is a marker of radiotherapy outcome in oropharyngeal squamous cell carcinoma

LB-100 enhances antitumor activity of combined veliparib/temozolomide treatment in vivo

Upsher-Smith Laboratories details development of extended-release topiramate formulation

Astellas Pharma claims new lysophospholipid LPA1 receptor antagonists

Aflibercept improves overall survival in phase III trial in metastatic colorectal cancer

TRAIL receptor agonist APG-350 potently induces apoptosis in cancer cells

Adeona Pharma completes trial of reaZin in patients with cognitive impairment

Centocor and Medivir patent new series of HCV NS5B inhibitors

Merck & Co. claims new mitogen-activated protein kinase inhibitors for cancer

Merck & Co. patents new positive allosteric modulators of muscarinic acetylcholine M1 receptor

A.P. Pharma meets with FDA to discuss NDA resubmission for APF-530

Rivastach patch is approved in Japan for Alzheimer's-type dementia

XenoPort and FDA agree on SPA for arbaclofen placarbil phase III trial

New ionotropic glutamate receptor agonists presented

FDA grants orphan drug status to active ingredient of Provectus Pharma's PV-10 in HCC

Genta begins tesetaxel trial in Japan in advanced cancer

Glubes approved in Japan to improve postprandial plasma glucose in patients with type 2 diabetes

IQ Therapeutics completes dosing in phase I IQNLF trial

European Commission approves Novartis' Rasilamlo for high blood pressure

Lipacreon approved in Japan as a pancreatic digestive enzyme replacement

FDA committee recommends approval of Victrelis for chronic HCV genotype 1 infection

FDA issues complete response letter regarding NDA for Aricept patch

Tarix Pharma enrolls first patient in phase I TXA-127 trial

Boehringer Ingelheim enrolls first patient in phase III BI-2013 trial in chronic hepatitis C

Baxter receives approval in Japan for inhaled anesthetic Suprane

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...